[1]岳朝艳. 女性抗苗勒管激素的临床应用新进展[J]. 中华临床实验室管理电子杂志,2015, 3(4):217-220
[2]Ye H. Significance of serum anti-Müllerian hormone detection in IVF[J]. J Reprod Med, 2015, 24(1):1-4.
[3]Hadlow N,Brown SJ,Habib A,et al.Quantifying the intraindividual variation of antimullerian hormone in the ovarian cycle[J].Fertil Steril,2016,106(5): 1230-1237.
[4]Broer SL, Broekmans FJ, Laven JS, et al. Ant-Müllerian hormone: ovarian reserve testing and its potential clinical implication[J].Hum Reprod Update,2014,20(5):688-701.
[5]邵一丹,梁元姣,陈莉,等.抗苗勒氏管激素下降率对多囊卵巢患者促排卵疗效的预测价值[J].医学研究生学报,2016,29(6):616-620
[6]Jamil Z,Fatima SS,Ahmed K,et al.Anti-mullerian hormone: Above and beyond conventional ovarian reserve markers[J].Disease Markers,2016:5246217.
[7]武学清,孔蕊,田莉,等. 卵巢低反应专家共识[J].生殖与避孕,2015,35(2):71-78.
[8]Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome[J]. Hum Reprod Update,2006,12(6):685-718.
[9]郑德燕,黄惠娟.环境因素对雌鼠卵巢损害的研究进展[J].东南国防医药,2015,17(5):511-513.
[10]梁玉婷,梁晓燕.卵巢储备功能减退及其检测方法评价[J].实用妇产科杂志,2015,31(1):2-4.
[11]赵玲,肖春辉.抗苗勒管激素水平在不同卵巢储备功能女性之间的差异[J].临床合理用药杂志,2013,6(3):38-40
[12]钱警语,陈秀娟.抗苗勒管激素与女性生育功能关系研究进展[J].生殖与避孕, 2013, 33(7):473-478.
[13]Andersen CY,Schmidt KT,Kristensen SG,et al. Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles[J].Hum Reprod,2010,25:1282-1287.
[14]Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Müllerian hormone in women[J]. Hum Reprod Update, 2014, 20(3):370-385.
[15]Fleming R, Kelsey TW, Anderson RA, et al. Interpreting human follicular recruitment and antimullerian hormone concentrations throughout life[J]. Fertil Steril,2012,98(5):1097-1102.
[16]张新云,李满桂,马秀清.抗苗勒管激素在临床中的应用与研究进展[J].青海医药杂志,2015,45(4):77-80
[17]任妞,刘彦.正常生育期女性血清抗苗勒管激素水平的研究[J].中国妇产科临床杂志,2011,12(4):281-283.
[18]张静.1160 例孕前保健妇女抗苗勒氏管激素筛查分析[J]. 中国妇幼保健, 2016,31(14):2837-2838.
[19]Yoo JH, Kim HO,Cha SW et al. Age specific serum anti-Müllerian hormone levels in 1,298 Korean women with regular menstruation[J].Clin Exp Reprod Med, 2011, 38(2):93-97.
[20]Tremellen K,Savulescu J.Ovarian reserve screening: a scientific and ethical analysis[J].Hum Reprod,2014,29 (12):2606-2614.
[21]肖雪晴, 张晓莉,李彦奇.不同民族女性不育患者抗苗勒氏管激素(AMH)水平分析[J]. 新疆医学,2014,44(11):36-40
[22]Kim SK,Lee JR,Jee BC,et al. What number of oocytes is appropriate for defining poor ovarian response[J]. Yonsei Med J,2015,56(2):482-489.
[23]Liberty G, Ben-Chetrit A, Margalioth E, et al. Does estrogen directly modulate anti-mullerian hormone secretion in women? [J] Fertil Steril, 2010,94(6):2253-2256.
[24]Piltonen T, Koivunen R, Morin-Papunen L, et al.Ovarian and adrenal steroid production: regulatory role of LH/HCG[J]. Hum Reprod, 2002,17(3):620-624.
[25]Shaw CM, Stanczyk FZ, Egleston BL, et al.Serum antimüllerian hormone in healthy premenopausal women[J]. Fertil Steril, 2011, 95(8):2718-2721.
[26]Hansen KR, Hodnett GM, Knowlton N, et al.Correlation of ovarian reserve tests with histologically determined primordial follicle number[J]. Fertil Steril, 2011, 95(1):170-175.